Skip to main content
Erschienen in:

22.10.2016 | Original Article

The diagnosis of endometrial atypia by hysteroscopy with guided biopsy in postmenopausal patients with hyperplasia: a reliable practice?

verfasst von: Siavash Rahimi, Carla Marani, Maria Emanuela Natale, Renato Zeloni, Raffaella Ruggeri, Natalia Povolotskaya, Robert Woolas

Erschienen in: Gynecological Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Atypical endometrial hyperplasia shows a high propensity to progress to endometrioid adenocarcinoma. Hysteroscopic biopsy represents a valid method for detection of this pre-neoplastic disease. This study assesses the accuracy of histological diagnosis of endometrial atypia in hysteroscopy with blind biopsy, in postmenopausal women with an endometrial thickness (ET) greater than 5 mm. In order, to determine the relationship between ET and atypia more precisely, ET was subdivided in three categories of 5–7 mm, ≥7–9 mm and >9 mm. Ninety-nine postmenopausal patients, aged 51–79 years, with abnormal uterine bleeding and an endometrial thickness >5 mm in whom a diagnosis of endometrial hyperplasia, with or without atypia, was established with hysteroscopy with biopsy, underwent subsequent hysterectomy. Hysteroscopy and biopsy were carried out using a blind endometrial biopsy guided by hysteroscopic findings. The results of biopsies and hysterectomy histology, for the presence of atypia, were compared. Sensitivity and likelihood ratio of hysteroscopic biopsy, as a diagnostic tool for detecting atypia, were calculated. The sensitivity in detecting atypia was 93.3 % corresponding to a negative likelihood ratio equal to 0.06. Univariate analysis did not show a significant association between atypia, age and/or endometrial thickness. The high sensitivity of hysteroscopic biopsy, corresponding to a strong negative likelihood ratio, made it a valid diagnostic tool for detecting atypia in postmenopausal women with abnormal uterine bleeding, hyperplasia and endometrial thickness >5 mm. There was no association between atypia and increase of endometrial thickness from 5 to >9 mm.
Literatur
1.
Zurück zum Zitat Karlsson B, Granberg S, Wikland M, Ryd W, Norstorm A (1993) Endovaginal scanning of the endometrium compared to cytology and histology in women with postmenopausal bleeding. Gynecol Oncol 50:173–178CrossRefPubMed Karlsson B, Granberg S, Wikland M, Ryd W, Norstorm A (1993) Endovaginal scanning of the endometrium compared to cytology and histology in women with postmenopausal bleeding. Gynecol Oncol 50:173–178CrossRefPubMed
2.
Zurück zum Zitat Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L (1990) Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119–123CrossRefPubMed Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L (1990) Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119–123CrossRefPubMed
3.
Zurück zum Zitat Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280(17):1510–1517CrossRefPubMed Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280(17):1510–1517CrossRefPubMed
4.
Zurück zum Zitat Tabor A, Watt HC, Wald NJ (2002) Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 99(4):663–670PubMed Tabor A, Watt HC, Wald NJ (2002) Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 99(4):663–670PubMed
5.
Zurück zum Zitat Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW (2010) Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 116(1):160–167CrossRefPubMed Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW (2010) Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 116(1):160–167CrossRefPubMed
6.
Zurück zum Zitat van Hanegem N, Breijer MC, Khan KS, Clark TJ, Burger MP, Mol BW, Timmermans A (2011) Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach. Maturitas 68(2):155–164CrossRefPubMed van Hanegem N, Breijer MC, Khan KS, Clark TJ, Burger MP, Mol BW, Timmermans A (2011) Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach. Maturitas 68(2):155–164CrossRefPubMed
7.
Zurück zum Zitat Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS (2002) Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 288(13):1610–1621CrossRefPubMed Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS (2002) Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 288(13):1610–1621CrossRefPubMed
8.
Zurück zum Zitat van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW (2007) Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 114(6):664–675CrossRefPubMed van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW (2007) Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 114(6):664–675CrossRefPubMed
9.
Zurück zum Zitat Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56:403–412CrossRefPubMed Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56:403–412CrossRefPubMed
10.
Zurück zum Zitat Ferenczy A, Gelfand M (1989) The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 160:126–131CrossRefPubMed Ferenczy A, Gelfand M (1989) The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 160:126–131CrossRefPubMed
11.
Zurück zum Zitat Lacey JV Jr, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N et al (2008) Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer 98:45–53CrossRefPubMed Lacey JV Jr, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N et al (2008) Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer 98:45–53CrossRefPubMed
12.
Zurück zum Zitat Widra EA, Dunton CJ, McHugh M, Palazzo JP (1995) Endometrial hyperplasia and the risk of carcinoma. Int J Gynecol Cancer 5:233–235CrossRefPubMed Widra EA, Dunton CJ, McHugh M, Palazzo JP (1995) Endometrial hyperplasia and the risk of carcinoma. Int J Gynecol Cancer 5:233–235CrossRefPubMed
13.
Zurück zum Zitat Hahn HS, Chun YK, Kwon YI, Kim TJ, Lee KH, Shim JU, Mok JE, Lim KT (2010) Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150(1):80–83CrossRefPubMed Hahn HS, Chun YK, Kwon YI, Kim TJ, Lee KH, Shim JU, Mok JE, Lim KT (2010) Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150(1):80–83CrossRefPubMed
14.
Zurück zum Zitat Mazur MT, Kurman RJ (1995) Endometrial hyperplasia and epithelial cytoplasmic change. In: Mazur MT, Kurman RJ (eds) Diagnosis of endometrial biopsies and curettings. A practical approach, 2rd edn. Springer-Verlag, New York, p. 168CrossRef Mazur MT, Kurman RJ (1995) Endometrial hyperplasia and epithelial cytoplasmic change. In: Mazur MT, Kurman RJ (eds) Diagnosis of endometrial biopsies and curettings. A practical approach, 2rd edn. Springer-Verlag, New York, p. 168CrossRef
15.
Zurück zum Zitat Emons G, Beckmann MW, Schmidt D, Mallmann P, for the Uterus commission of the Gynecological Oncology Working Group (AGO) (2015) New WHO classification of endometrial hyperplasias (Neue WHO-Klassifikation der Endometriumhyperplasien). Geburtshilfe Frauenheilkd 75(2):135–136CrossRefPubMedPubMedCentral Emons G, Beckmann MW, Schmidt D, Mallmann P, for the Uterus commission of the Gynecological Oncology Working Group (AGO) (2015) New WHO classification of endometrial hyperplasias (Neue WHO-Klassifikation der Endometriumhyperplasien). Geburtshilfe Frauenheilkd 75(2):135–136CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Zaino R, Carinelli SG, Ellenson LH (2014) Tumours of the uterine corpus: epithelial tumours and precursors. WHO Press, Lyon, pp. 125–126 Zaino R, Carinelli SG, Ellenson LH (2014) Tumours of the uterine corpus: epithelial tumours and precursors. WHO Press, Lyon, pp. 125–126
17.
Zurück zum Zitat Lacey JV Jr, Chia VM (2009) Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 63(1):39–44CrossRefPubMed Lacey JV Jr, Chia VM (2009) Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 63(1):39–44CrossRefPubMed
18.
Zurück zum Zitat Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, Jordan CD, Epplein M, Swisher E, Upson K, Ehrlich KJ, Noel Weiss NS (2010) Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy. Obstet Gynecol 116:365–373CrossRefPubMedPubMedCentral Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, Jordan CD, Epplein M, Swisher E, Upson K, Ehrlich KJ, Noel Weiss NS (2010) Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy. Obstet Gynecol 116:365–373CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Allison KH, Reed SD, Voigt LF, Jordan CD, Newton KM, Garcia RL (2008) Diagnosing endometrial hyperplasia: why is it so difficult to agree? Am J Surg Pathol 32(5):691–698CrossRefPubMedPubMedCentral Allison KH, Reed SD, Voigt LF, Jordan CD, Newton KM, Garcia RL (2008) Diagnosing endometrial hyperplasia: why is it so difficult to agree? Am J Surg Pathol 32(5):691–698CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, Gallup DG (2006) Reproducibility of the diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer 106(4):804–811CrossRefPubMed Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, Gallup DG (2006) Reproducibility of the diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer 106(4):804–811CrossRefPubMed
21.
Zurück zum Zitat Skov BG, Broholm H, Engel U, Franzmann MB, Nielsen AL, Lauritzen AF, Skov T (1997) Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol 16(1):33–37CrossRefPubMed Skov BG, Broholm H, Engel U, Franzmann MB, Nielsen AL, Lauritzen AF, Skov T (1997) Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol 16(1):33–37CrossRefPubMed
22.
Zurück zum Zitat Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ et al (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer 106:812–819CrossRefPubMed Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ et al (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer 106:812–819CrossRefPubMed
23.
Zurück zum Zitat Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E et al (1999) A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23:1102–1108CrossRefPubMed Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E et al (1999) A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23:1102–1108CrossRefPubMed
24.
Zurück zum Zitat Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22:1012–1019CrossRefPubMed Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22:1012–1019CrossRefPubMed
25.
Zurück zum Zitat Mutter GL, The Endometrial Collaborative Group (2000) Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? Gynecol Oncol 76(3):287–290CrossRef Mutter GL, The Endometrial Collaborative Group (2000) Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? Gynecol Oncol 76(3):287–290CrossRef
26.
Zurück zum Zitat Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D (2015) Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis Obgyn 7(1):17–24PubMedPubMedCentral Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D (2015) Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis Obgyn 7(1):17–24PubMedPubMedCentral
27.
Zurück zum Zitat Connor M (2015) New technologies and innovations in hysteroscopy. Best Pract Res Clin Obstet Gynaecol 29(7):951–965CrossRefPubMed Connor M (2015) New technologies and innovations in hysteroscopy. Best Pract Res Clin Obstet Gynaecol 29(7):951–965CrossRefPubMed
Metadaten
Titel
The diagnosis of endometrial atypia by hysteroscopy with guided biopsy in postmenopausal patients with hyperplasia: a reliable practice?
verfasst von
Siavash Rahimi
Carla Marani
Maria Emanuela Natale
Renato Zeloni
Raffaella Ruggeri
Natalia Povolotskaya
Robert Woolas
Publikationsdatum
22.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Gynecological Surgery / Ausgabe 4/2016
Print ISSN: 1613-2076
Elektronische ISSN: 1613-2084
DOI
https://doi.org/10.1007/s10397-016-0985-x

Neu im Fachgebiet Gynäkologie und Geburtshilfe

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Keine eingeschränkten Kassenleistungen bei Schwangerschaft nach IVF

Nach privat bezahlter In-vitro-Fertilisation muss die gesetzliche Krankenkasse ein Arzneimittel zum Erhalt der Schwangerschaft bezahlen, so ein Urteil des Sozialgerichts in München.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.